GM vs IKT · P/E 7.5, rev $91.65B vs $215.2M cap
General Motors Company (GM) versus Inhibikase Therapeutics Inc (IKT) — a side-by-side from cached financials, not a winner call.
General Motors Company (GM) is a auto manufacturers company listed on US. It is led by Mary Barra.
Inhibikase Therapeutics Inc (IKT) is a biotechnology company listed on US.
Latest reported GM revenue for 2026-06-30 was $91.65B. Net income was $3.93B. GM currently screens at market cap $51.33B and trailing P/E 7.5.
Latest reported IKT revenue for 2026-06-30 was $0. Net income was -$36.0M. IKT currently screens at market cap $215.2M.
GM currently screens at market cap $51.33B and trailing P/E 7.5. IKT currently screens at market cap $215.2M.
Not investment advice. Open the GM and IKT stock pages for the full models.
Not investment advice.